References
- Hollander D. The intestinal permeability barrier. A hypotesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 1992; 27: 721–6
- May G R, Sutherland L R, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn's disease. Gastroenterology 1993; 104: 1627–32
- Olaison G, Sjödahl R, Tagesson C. Abnormal permeability in Crohn's disease. A possible pathogenic factor. Scand J Gastroenterol 1990; 25: 321–8
- Teahon K, Smethurst P, Levi A J, Menzies I S, Bjarnason I. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 1992; 33: 320–3
- Wyatt J, Vogelsang Hübl W, Waldhoer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993; 341: 1437–9
- Anderson R, Lærum F, Bay D, Aas K, Halstensen T S, Stordahl A. Experimental colonic inflammation and ulceration. Permeation of water-soluble contrast medium as a measure of ‘disease’ activity. Scand J Gastroenterol 1992; 27: 757–63
- Andersen R, Hosaka J, Halstensen T S, Stordahl A, Tverdal A, Aabakken L. The X-ray contrast medium iodixanol detects increased colonic permeability equally well as 51Cr-labeled ethylenediaminetetraacetic acid in experimental colitis of rats. Scand J Gastroenetrol 1996; 31: 140–6
- Halme L, Edgren J, Von Smitten K, Linden H. Increased urinary excretion of iohexol after enteral administration on patients with ileal Crohn's disease-a new test for disease activity. Acta Radiol 1993; 34: 237–41
- Myren J, Bouchier I A, Watkinson G, Softley A, Clamp S E, De Dombal FT. The OMGE multinational inflammatory bowel disease survey 1976–1982. A further report of 2657 cases. Scand J Gastroenterol 1984; 23: 1–27, Suppl 95
- Truelove S C, Witts LJ. Cortisone in ulcerative colitis report on a therapeutical trial. Br Med J 1955; 2: 1041–8
- Edelson J, Palace G, Park G. High-performance liquid chromatographic determination of iohexol in plasma urine and feces. J Chromatogr 1983; 274: 428–33
- Skinnemoen K, Fagervoll R, Jacobsen T. Determination of iopentol and other non-ionic contrast agents in biologic fluids by high performance liquid chromatography. Acta Radiol 1987; 23–5, Suppl 370
- Turpeinen U, Pomoell UM. Liquid chromatographic determination of meglumine diatrizoate in human plasma and urine. J Chromatogr 1986; 377: 460–5
- Munkholm P, Langholz E, Hollander D, Thornberg K, Orholm M, Katz K D. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 1994; 35: 68–72
- Stordahl A. Urinary excretion of enteral iohexol in rats with intestinal ischaemia. The influence on size of ishaemic area and duration of exposure to contrast medium. Scand J Gastroenterol 1988; 23: 983–90
- Solheim K E, Lærum F, Stordahl A, Aase S. Urinary excretion of iohexol after enteral administration in rats with radiation injury of the small intestine. Scand J Gastroenterol 1991; 26: 1097–106
- Andersen R, Stordahl A, Høyseth H, Koppers R, Aa Tverdahl, Aase S. Increased intestinal permeability for the isomolar contrast medium iodixanal during small-bowel ischaemia in rats. Scand J Gastroenterol 1995; 30: 1082–8
- Brignola C, Campieri M, Bazzocchi G, Farruggia P, Tragnone A, Lanfranchi GA. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology 1986; 91: 1490–4
- Fischbach W, Becker W, Mössner J, Koch W, Reiners C. Faecal alpha-1-antitrypsin and excretion of Indium granulocytes in assessment of disease activity in chronic inflammatory bowel disease. Gut 1987; 28: 386–93
- Stordahl A, Lærum F, Gjoelberg T, Enbe I. Water-soluble contrast media in radiography of small bowel obstruction. Comparison of ionic and non-ionic contrast media. Acta Radiol 1988; 29: 53–5
- Andersen R. Letter to editor. Acta Radiol 1995; 39: 697